Legend Biotech (LEGN) EBT (QoQ) (2019 - 2025)
Legend Biotech (LEGN) EBT (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.58% |
| Sep 30, 2025 | 68.69% |
| Jun 30, 2025 | -25.89% |
| Mar 31, 2025 | -344.16% |
| Dec 31, 2024 | 133.59% |
| Sep 30, 2024 | -572.71% |
| Jun 30, 2024 | 69.94% |
| Mar 31, 2024 | 59.28% |
| Dec 31, 2023 | -134.92% |
| Sep 30, 2023 | 68.57% |
| Jun 30, 2023 | -77.58% |
| Mar 31, 2023 | 17.50% |
| Dec 31, 2022 | -60.04% |
| Sep 30, 2022 | 56.08% |
| Jun 30, 2022 | -500.98% |
| Mar 31, 2022 | 63.63% |
| Dec 31, 2021 | 29.19% |
| Sep 30, 2021 | 27.63% |
| Jun 30, 2021 | -182,121.91% |
| Mar 31, 2021 | 99.84% |